Advances in Rheumatology Practice in Brazil
Overview
Affiliations
Despite resilient inequities, Brazil has seen progressive improvement in health care in the last 25 years. Infectious diseases rendered place to chronic non-communicable diseases as a major cause of death. Existence of traditional schools of medicine and training services in rheumatology helped form a reasonable number of specialists, though irregular distribution due to the economic issues favoring their clustering in major cities. The Brazilian Society of Rheumatology provides continued medical education, helps training rheumatologists, family physicians and other health professionals and has worked to publish national recommendations for the diagnosis and treatment of major rheumatic diseases. Access to medications and health care facilities is provided for most patients, free of direct charge, including biologics. Specialized services for autoimmune and rare diseases, including pediatric rheumatology and autoinflammatory diseases, have improved, particularly in developed centers of the southern best developed parts of the country. A major unmet need is the lack of access to non-pharmacological treatment modalities. In this article, we will summarize some of the strengths and points that need improvement to enhance access to the rheumatological health care in Brazil.
Mineiro L, Gallo da Silva T, Valderramas S, Kowalski S, Dos Santos Paiva E, Gomes A Adv Rheumatol. 2024; 64(1):5.
PMID: 38167406 DOI: 10.1186/s42358-023-00341-z.
Silva C, Teixeira G, de Brito G, Lacerda M, Rocha F BMC Musculoskelet Disord. 2024; 25(1):13.
PMID: 38167047 PMC: 10759598. DOI: 10.1186/s12891-023-07124-z.
Silva C, Mourao N, da Rocha L, Landim J, Rocha H, Lacerda M BMC Musculoskelet Disord. 2021; 22(1):714.
PMID: 34419023 PMC: 8380319. DOI: 10.1186/s12891-021-04599-6.
da Silva G, Landim J, Dos Santos Brasil L, Plens I, Silva A, Aaron Scheinberg M Rheumatol Int. 2020; 41(5):939-942.
PMID: 32767082 DOI: 10.1007/s00296-020-04674-6.
Rocha F, Landim J, Nour M, Filho V, da Rocha L, da Silva M Clin Rheumatol. 2019; 38(8):2227-2231.
PMID: 31062254 DOI: 10.1007/s10067-019-04582-6.